Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

6-Phenyl-5a,6,6a,7,12,13a-hexa-hydro-5H-benzo[6,7]indolizino[3,2-a]pyrrolizine.

ABSTRACT: In the title compound, C(23)H(22)N(2), the central pyrrolidine ring adopts an envelope conformation. The benzene ring of the hexa-hydro-pyrroloisoquinoline ring system makes dihedral angles of 83.43?(6) and 61.99?(10)°, respectively, with the phenyl and pyrrole rings. In the crystal structure, weak C-H?? inter-actions are observed.

SUBMITTER: Gunasekaran B

PROVIDER: S-EPMC2969265 | biostudies-literature | 2009 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

6-Phenyl-5a,6,6a,7,12,13a-hexa-hydro-5H-benzo[6,7]indolizino[3,2-a]pyrrolizine.

Gunasekaran B B Kathiravan S S Raghunathan R R Renuga V V Manivannan V V

Acta crystallographica. Section E, Structure reports online 20090606 Pt 7

In the title compound, C(23)H(22)N(2), the central pyrrolidine ring adopts an envelope conformation. The benzene ring of the hexa-hydro-pyrroloisoquinoline ring system makes dihedral angles of 83.43 (6) and 61.99 (10)°, respectively, with the phenyl and pyrrole rings. In the crystal structure, weak C-H⋯π inter-actions are observed. ...[more]

PMID: 21582758

Similar Datasets

1-Acetyl-4-phenyl-5a,6,7,8,9,9a-hexa-hydro-5H-1,5-benzodiazepin-2(1H)-one.

Project description:The seven-membered ring of the title compound, C(17)H(20)N(2)O(2), adopts an approximate boat conformation while the cyclo-hexyl ring adopts a chair conformation. In the crystal, adjacent mol-ecules are linked by N-H?O hydrogen bonds into a zigzag chain running along the c axis of the monoclinic unit cell.

| S-EPMC2971313 | biostudies-literature

5-Phenyl-3,4,4a,5,6,12c-hexa-hydro-2H-benzo[f]pyrano[3,2-c]quinoline.

Project description:In the title compound, C(22)H(21)N, the pyridine ring adopts a distorted boat conformation, while the adjacent pyran ring adopts a chair conformation; the heterocyclic rings make a dihedral angle of 40.1 (2)° with each other.

| S-EPMC3006965 | biostudies-literature

4-(4-Bromo-phen-yl)-2,3,3a,4,5,11c-hexa-hydro-benzo[f]furo[3,2-c]quinoline.

Project description:In the title compound, C(21)H(18)BrNO, both heterocyclic rings, viz. the hydro-pyridine ring and the adjacent hydro-furan ring, adopt envelope conformations. These two heterocycles make a dihedral angle of 37.3?(1)°. The dihedral angle between the hydro-pyridine and benzene rings is 69.6?(1)°. In the crystal, adjacent mol-ecules are linked by pairs of inter-molecular C-H?O hydrogen bonds, forming centrosymmetric dimers.

| S-EPMC3200627 | biostudies-literature

Crystal structure of 15-(naphthalen-1-yl)-7,7a,8,9,10,11-hexa-hydro-6a,12a-(methano-epoxy-methano)-indolizino[2,3-c]quinoline-6,13(5H)-dione.

Project description:In the title compound, C27H24N2O3, the dihedral angle between the mean planes of the di-hydro-furan and 3,4-di-hydro-quinoline ring systems is 70.65 (9)°. The di-hydro-furan ring adopts an envelope conformation with the C atom adjacent to the methyl-ene C atom of the pyrrolidine ring as the flap. The five-membered pyrrolidine ring adopts a twist conformation on the N-C(tetra-substituted) bond. In the crystal, mol-ecules are linked via pairs of N-H⋯O hydrogen bonds, forming inversion dimers with an R 2 (2)(8) ring motif. The dimers are linked via pairs of C-H⋯O hydrogen bonds, forming ribbons enclosing R 2 (2)(12) ring motifs lying in a plane parallel to (01-1).

| S-EPMC4350735 | biostudies-literature

Methyl 4-(4-chloro-phen-yl)-3,3a,4,4a,5,12c-hexa-hydro-2-thia-naphtho-[1',2':3,2]furo[5,4-b]pyrrolizine-4a-carboxyl-ate.

Project description:In the title compound, C(25)H(22)ClNO(3)S, both the pyrrolidinyl and thia-zolyl rings adopt envelope conformations whereas the dihydro-pyran ring adopts a half-chair conformation. The chloro-phenyl and naphthalenyl ring systems are oriented at a dihedral angle of 59.7?(1)°. The crystal packing is stabilized by an intra-molecular C-H?N hydrogen bond and weak inter-molecular C-H?? inter-actions.

| S-EPMC3007469 | biostudies-literature

1-Methyl-1'-(4-methyl-phen-yl)-2',3',5',6',7',7a'-hexa-hydro-1'H-dispiro-[piperidine-3,2'-pyrrolizine-3',3''-indoline]-4,2''-dione.

Project description:The title compound, C(26)H(29)N(3)O(2), crystallizes with two mol-ecules in the asymmetric unit, having C-H⋯O inter-actions between them and resulting in a dimer characterized by an R(2) (2)(11) motif. These dimers are linked into an ABABAB chain via N-H⋯O, N-H⋯N and C-H⋯O built edge-fused R(1) (2)(5) and R(2) (2)(7) motifs. This chain is linked to its inversion-related partner via N-H⋯O bonds with an R(2) (2)(8) motif and leads to a double chain extending along the b axis characterized by an R(6) (6)(36) motif across the inversion centres. The methyl group of the phenyl ring and the oxindole of mol-ecule A and B are involved in C-H⋯π inter-actions. One C atom of the pyrrolizine ring of mol-ecule A and its attached H atoms show positional disorder, the major and minor components being in the ratio 0.706 (7):0.294 (7).

| S-EPMC3435806 | biostudies-literature

1'-Allyl-1-(3,4-di-methyl-benzo-yl)-2-(4-methyl-1,3-thia-zol-5-yl)-1,2,5,6,7,7a-hexa-hydro-spiro-[pyrrolizine-3,3'-indolin]-2'-one.

Project description:In the title compound, C30H31N3O2S, the fused pyrrolidine ring bearing three substituents adopts an envelope conformation with the C atom bearing the benzoyl group as the flap. The other fused pyrrolidine ring adopts a twisted conformation about one of its C-C bonds. The dihedral angle between the isatin ring system and the methyl-thia-zole ring is 25.95?(8)°. An intra-molecular C-H?O inter-action closes an S(8) ring. In the crystal, mol-ecules are linked by C-H?O inter-actions, generating C(11) chains propagating in [001].

| S-EPMC4011234 | biostudies-literature

1'-(1,3-Diphenyl-1H-pyrazol-4-yl)-1''-(prop-2-en-1-yl)-2',3',5',6',7',7a'-hexa-hydro-1'H-di-spiro-[1-benzo-pyran-3,2'-pyrrolizine-3',3''-indoline]-2'',4-dione 0.75-hydrate.

Project description:In the central aza-bi-cyclo-octane unit of the title compound, C40H34N4O3·0.75H2O, the peripheral pyrrolidine ring adopts an envelope conformation with the N atom deviating by 0.209?(2)?Å, whereas the other pyrrolidine ring adopts a twisted conformation with the bridging N and C atoms deviating by -0.218?(2) and 0.236?(3)?Å, respectively, from the rest of the ring. The pyrazole ring forms dihedral angles of 42.36?(7) and 24.07?(8)° with its C- and N-attached phenyl groups, respectively. The solvent water mol-ecule has a partial occupancy of 0.75. In the crystal, the water mol-ecules link the fused-ring mol-ecules into chains along the b axis via O-H?N and O-H?O hydrogen bonds. The crystal packing is further stabilized by C-H?? inter-actions involving a methyl-ene group of the pyran ring and the C-attached benzene ring on the pyrazole ring.

| S-EPMC3793707 | biostudies-literature

8-Methyl-4-phenyl-2,3,3a,4,5,9b-hexa-hydro-furo[3,2-c]quinoline.

Project description:The title compound, C(18)H(19)NO, was synthesized from the multi-component one-pot reaction between p-toluidine, benzaldehyde and 2,3-dihydro-furan in the presence of palladium dichloride. There are two mol-ecules in the asymmetric unit. The crystal packing is stabilized by classical inter-molecular N-H?O hydrogen bonds.

| S-EPMC2980039 | biostudies-literature

Crystal structure of 6,7-dihy-droxy-6,7-di-hydro-3H-imidazo[1,2-a]purin-9(5H)-one.

Project description:The title purine derivative, C7H7N5O3, is an adduct of guanine with glyoxal. In the mol-ecule, the di-hydro-imidazole ring adopts a twisted conformation on the C-C bond, and the two hydroxyl groups lie on opposite sides of the mean plane of the ring. In the crystal, the mol-ecules are linked by N-H?O, O-H?N and N-H?N hydrogen bonds forming a three-dimensional framework. The crystal packing is reinforced by C-H?O hydrogen bonds and by offset ?-? stacking of the purine ring systems of inversion related mol-ecules [inter-centroid distance = 3.4839?(12)?Å].

| S-EPMC4971859 | biostudies-other

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data